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Abstract
Alpha-synuclein (α-Syn) overexpression and misfolding/aggregation in degenerating 
dopaminergic neurons have long been implicated in Parkinson’s disease (PD). The neurotoxicity 
of α-Syn is enhanced by iron (Fe) and other pro-oxidant metals, leading to generation of reactive 
oxygen species in PD brain. Although α-Syn is predominantly localized in presynaptic nerve 
terminals, a small fraction exists in neuronal nuclei. However, the functional and/or pathological 
role of nuclear α-Syn is unclear. Following up on our earlier report that α-Syn directly binds DNA 
in vitro, here we confirm the nuclear localization and chromatin association of α-Syn in neurons 
using proximity ligation and chromatin immunoprecipitation analysis. Moderate (~2-fold) increase 
in α-Syn expression in neural lineage progenitor cells (NPC) derived from induced pluripotent 
human stem cells (iPSCs) or differentiated SHSY-5Y cells caused DNA strand breaks in the 
nuclear genome, which was further enhanced synergistically by Fe salts. Furthermore, α-Syn 
required nuclear localization for inducing genome damage as revealed by the effect of nucleus 
versus cytosol-specific mutants. Enhanced DNA damage by oxidized and misfolded/oligomeric α-
Syn suggests that DNA nicking activity is mediated by the chemical nuclease activity of an 
oxidized peptide segment in the misfolded α-Syn. Consistent with this finding, a marked increase 
in Fe-dependent DNA breaks was observed in NPCs from a PD patient-derived iPSC line 
harboring triplication of the SNCA gene. Finally, α-Syn combined with Fe significantly promoted 
neuronal cell death. Together, these findings provide a novel molecular insight into the direct role 
*Correspondence to: Muralidhar L. Hegde, PhD, Department of Radiation Oncology, Houston Methodist Research Institute, Fannin 
St., Smith 8-05, Houston, Texas 77030, USA. Tel.: +1 713 441 7456; Fax: +1 713 790 3755; mlhegde@houstonmethodist.org. and 
K.S. Rao, Centre for Neuroscience, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), City of 
Knowledge, Republic of Panama. kjr5n2009@gmail.com. 
SUPPLEMENTARY MATERIAL
The supplementary material is available in the electronic version of this article: http://dx.doi.org/10.3233/JAD-170342.
HHS Public Access
Author manuscript
J Alzheimers Dis. Author manuscript; available in PMC 2018 October 05.
Published in final edited form as:
J Alzheimers Dis. 2017 ; 60(Suppl 1): S133–S150. doi:10.3233/JAD-170342.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of α-Syn in inducing neuronal genome damage, which could possibly contribute to 
neurodegeneration in PD.
Keywords
Alpha-synuclein; iPSC-derived neural progenitor cells; iron; neurodegeneration; Parkinson’s 
disease
INTRODUCTION
Alpha-synuclein (α-Syn) is a 140 amino acid-containing, intrinsically disordered protein 
found to be differentially expressed with age and subtypes of neurons in vertebrates [1, 2]. 
Missense mutations and triplication of α-Syn encoding SNCA gene have been linked to 
neurodegeneration in Parkinson’s disease (PD) and related disorders [3–5]. The factors 
triggering α-Syn mediated neurotoxicity in sporadic PD cases are still vague; however, 
multiple lines of evidence link pro-oxidant metal dyshomeostasis in affected brain regions 
and oxidative stress to α-Syn aggregation [6–8]. The interaction of α-Syn with iron (Fe) or 
copper (Cu) not only affects its folding properties but also its interaction with other 
macromolecules, including membrane lipids, and cellular localization [9–11]. Furthermore, 
α-Syn has been shown to oxidize both in vitro and in cell under PD conditions [12, 13]. 
While the biological implications of these modifications have not been investigated, 
oxidation seems to promote α-Syn misfolding in vitro [14, 15].
α-Syn is localized predominantly in the neuronal cytosol and is membrane-bound in 
presynaptic nerve terminals, although several studies identified a small fraction of the 
protein in other cellular compartments, including the mitochondria and the nucleus [16–22]. 
Although there are discrepancies in the literature about the presence of α-Syn in the nuclei 
of healthy neurons, presumably due to varying sensitivity of the detection methods 
employed, there is more consistent evidence supporting its nuclear localization in PD-
affected neurons [23–25]. While the relative abundance of α-Syn in the nucleus versus 
cytoplasm in various cell types has not been thoroughly investigated, it appears that about 5–
10% of α-Syn localizes to the nucleus in cultured neurons. Nonetheless, the precise role of 
nuclear α-Syn in normal or PD-affected neurons is not known. We previously showed that 
recombinant α-Syn binds naked DNA in vitro, resulting in conformational changes in DNA 
and protein [26, 27]. Subsequent studies from other laboratories not only confirm this 
observation but also demonstrate its association with histone H3 in neuroblastoma cells, 
suggesting its possible role in chromatin [23]. Interestingly, a recent study shows that α-Syn 
selectively binds to promoter regions of several genes in oxidatively stressed cells, 
suggesting its involvement in transcriptional regulation [21]. We previously showed affinity 
of α-Syn for guaninecytosine-rich DNA sequences, a scenario consistent with its proposed 
promoter activity [28].
One major feature of PD pathology is the accumulation of various types of genome damage 
in affected neurons [29]. Interestingly, the level of DNA damage accumulation in PD-
affected brain regions seems to broadly correlate with disease severity, which is linked to α-
Syn pathology and metal accumulation/oxidative stress [29–31]. However, a direct link 
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between α-Syn toxicity and genome damage has not been investigated. Here, we tested the 
hypothesis that nuclear α-Syn together with transition metals contribute to neuronal genome 
damage in PD. Using multiple in vitro neuronal models, including neurons from normal and 
PD patient-derived induced pluripotent stem cells (iPSCs) and α-Syn inducible 
neuroblastoma line, we demonstrate here for the first time that α-Syn not only associates 
with chromatin but it also induces DNA breaks in chromatin upon oxidation, leading to 
neuronal apoptosis. Furthermore, the DNA damage accumulation is dependent on 
chromatin-bound α-Syn in the neuronal nuclei, consistent with its DNA nicking activity in 
vitro, both of which are facilitated by pro-oxidant Fe and α-Syn misfolding. This novel 
observation reveals a direct role of α-Syn in causing genome damage and neuronal death in 
PD.
MATERIALS AND METHODS
Plasmid constructs
pcDNA-NES-α-Syn and pcDNA-NLS-α-Syn plasmids containing additional nuclear 
localization signal (NLS) or nuclear export signal (NES) sequences were a kind gift from Dr. 
Mel B. Feany (Harvard Medical School) [23]. Inducible mammalian FLAG-α-Syn 
expression vector was generated by cloning blunt-ended full-length α-Syn amplified from 
pcDNA-WT-α-Syn plasmid using Deep Vent DNA polymerase (M0258, NEB) into pCW-
Cas9 vector (gift from Eric Lander and David Sabatini, Addgene plasmid 50661) [32] and 
digested with restriction enzymes NheI (R0131, NEB) and BamHI (R0136, NEB) followed 
by DNA polymerase I, large (Klenow; M0210, NEB) treatment to generate blunt ends. The 
primers used to amplify C-terminal FLAG-tagged α-Syn were as follows: forward primer, 
5’-ATG GAT GTA TTC ATG AAA GGA CT-3’; reverse primer, 5’–CAC TGT CGA CTT 
ACT TAT CGT CAT CGT CTT TGT AAT CGG CTT CAG GTT CGT AGT CTT GAT 
ACC-3’.
Cell culture and treatments
The human neuroblastoma SHSY-5Y line was routinely maintained in regular Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS; 
Gibco) and 1% penicillin/streptomycin (Corning). Transfection of SHSY-5Y cells with 
pcDNA-NES-α-Syn, pcDNANLS-α-Syn, and pCW-FLAG-α-Syn plasmids was carried out 
using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. NLS- 
and NES-tagged α-Syn plasmid-transfected cells were selected with antibiotic G418 
sulphate (Corning), and doxycycline (Dox)-inducible α-Syn-expressing cells were selected 
against the antibiotic puromycin (InvivoGen) with a dose of 10 μg/mL.
Dox (5 μg/mL for 0, 24, 48, or 72 h)-inducible (i) FLAG-α-Syn levels were optimized for 2–
3-fold overexpression. The cells were treated with FeSO4 (200 μM) or CuSO4 (200 μM) in 
DMEM supplemented with 1% FBS media for 24 h.
Human iPSC culture and generation of neural progenitor cells (NPC)
A control iPSC line KYOU-DXR0109B (201B7) was obtained from ATCC and grown in 
CellMatrix basement membrane gel (ACS-3035) and Pluripo-tent Stem Cell SFM XF/FF 
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media (ACS-3002) at 37°C and 5% CO2. The iPSC line (ND34391*H) with α-Syn SNCA 
gene triplication (SNCA-tri) was obtained from the CORIELL Institute cell repository. 
SNCA-tri iPSCs were initially grown in 0.1% gelatin-coated 6-well plates covered with γ-
irradiated CF-1 mouse embryonic fibroblasts and DMEM/F12 20% knock-out serum 
replacement (Gibco 11330–032, 10828010). At passage 3, SNCA-tri iPSCs were 
transitioned into a feeder-free system and maintained in a CellMatrix-coated dish and 
Essential 8 medium (E8M; Gibco A1517001). Derivation of NPCs from both control and 
SNCA-tri iPSCs was done using PSC neural induction medium (Gibco A1647801) as per 
the manufacturer’s protocol. Briefly, E8M was replaced with neural induction medium 
approximately 24 h after passaging iPSCs, which were maintained in this medium for 7 
days. Then the NPCs (P0) were passaged onto Geltrex (Thermo Fisher)-coated 6-well plates 
and expanded in StemPRO neural stem cell SFM media (A1050901). Neural induction 
efficiency was determined at passage 3 by immunofluorescence staining with a pluripotent 
marker (Oct4) and neural lineage stem cell marker (Nestin).
Real Time-PCR analysis for α-Syn mRNA quantitation
Total RNA was isolated using RNeasy Mini Kit (Qiagen #74104) following the 
manufacturer’s protocol. Two microgram RNA was used for cDNA synthesis in a 20 μL 
reaction using SuperScript III reverse transcriptase kit (Invitrogen, #18080–044). α-Syn 
expression in the samples were analyzed by SYBR GREEN-based Real Time PCR (7000 
Real-Time PCR System; Applied Biosystems) using SYBR Premix Ex Taq (TaKaRa) and 
primers appropriate for α-Syn expression described in [33] (HaSynTfw 5’-AGG GTG TTC 
TCT ATG TAG G-3’ HaSynTrv 5’-ACT GTC TTC TGG GCT ACT GC) and HPRT1 
expression (internal control; primer sequences: RealTimePrimers.com). Data were 
represented as fold change mRNA expression with respect to the reference samples set at 1 
based on 2–ΔΔCT method.
Electrophoresis and immunoblotting
Whole cell protein extracts were obtained by harvesting the cells in ice-cold phosphate-
buffered saline (PBS) and lysing them with STEN lysis buffer (50 mM Tris-HCl (pH 7.6), 
150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 2 mM EDTA, and protease inhibitor) on ice 
for 20 min. Cytoplasmic and nuclear fraction protein were obtained by first lysing the 
harvested cells in cytoplasmic buffer (10 mM Tris-HCl (pH 7.9), 0.34 M sucrose, 3.0 mM 
CaCl2, 2.0 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Nonidet P-40, and protease 
inhibitor) on ice for 10 min followed by centrifugation at 3500 g for 15 min at 4°C. 
Supernatant was collected as the cytoplasmic fraction, and the pellet was lysed with nuclear 
lysis buffer (20 mM HEPES (pH 7.9),3.0 mM EDTA, 10% glycerol, 150 mM potassium 
acetate, 1.5 mM MgCl2, 1 mM DTT, and 0.5% Nonidet P-40), vortexed for 15 min at 4°C, 
and centrifuged at 16000 g for 10 min at 4°C. Protein content was estimated using the 
Bradford method (Bio-Rad).
Gel electrophoresis was performed as described previously [34, 35]. Protein samples were 
prepared for electrophoresis by dilution with their corresponding lysis buffers and addition 
of 4 × NuPAGE LDS samples; samples were not subjected to boiling. If not stated 
otherwise, 30 μg protein was loaded per lane in NuPAGE 4–12% Bis-Tris gel and 
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electrophoresed with NuPAGE MES-SDS running buffer. Gels were then electroblotted onto 
Immobilon-PSQ 0.45-μm PVDF membranes (Millipore) for 3 h at 30 V constant current at 
4°C in 1 × Tris-Glycine solution (Fisher Scientific) and 20% methanol transfer buffer. After 
transfer, membranes were fixed with 0.4% paraformaldehyde (PFA) in PBS for 30 min at 
room temperature (RT), followed by blocking in 5% skim milk in TBS-T. The membranes 
were incubated with primary antibody diluted in 1% skim milk in TBST for 1 h at RT or 
overnight at 4°C, followed by washing in 1 × TBS-T and then incubation with secondary 
antibody for 1 h at RT and development with SuperSignal West Pico Chemiluminescent 
Substrate (Thermo Fisher).
Proximity ligation assay (PLA)
About 20,000 cells were seeded per well in 8-well chamber slides (Millipore) and grown for 
2 days with Dox (5 μg/mL) induction. After the indicated treatment, the cells were fixed 
with 4% PFA for 15 min in the dark at RT, permeabilized in 0.2% Triton X-100 (Sigma) in 
1× PBS for 10 min at RT, washed with PBS, blocked with 100 mM glycine, and washed 
again with PBS. The in situ PLA experiment was performed using the DuoLink kit (Olink 
Biosciences, Uppsala, Sweden) following the manufacturer’s instructions. The following 
primary antibodies were used at the specified dilutions: mouse anti-FLAG at 1:1000; rabbit 
anti-α-Syn at 1:200, and rabbit anti-histone 3 at 1:200 dilution. The nuclear background of 
cells was visualized by staining with 4’,6-diamidino-2-phenylindole (DAPI; Agilent 
Technologies). After staining, cells were examined with a Zeiss Axio Observer 7 
microscope.
Chromatin immunoprecipitation (ChIP) assay
ChIP analysis was performed following the procedure described previously [36–38]. Briefly, 
cells in 10-cm plates were washed with PBS, cross-linked with 1% formaldehyde, lysed, and 
sonicated (XL-2000; QSonica LLC). IP was then performed in the cleared lysate with 5 μg 
of FLAG antibody (Sigma, for FLAG-α-Syn) or control IgG (Santa Cruz Biotechnology, 
Inc.) and Magna ChIP Protein A magnetic beads (Millipore, catalog no. 16–661) overnight. 
After washing the IP beads, protein-DNA complexes were eluted and the cross-links were 
reversed. DNA was purified using standard phenol/chloroform extraction and finally 
dissolved in 10 mM Tris-HCl (pH 8). The ChIP and 1% of the input DNA were subjected to 
SYBR Green-based real-time PCR (7500 Real-Time PCR System; Applied Biosystems) 
with appropriate primers (Supplementary Table S1) and SYBR Premix Ex Taq (TaKaRa). 
ChIP data were calculated as percent input.
Biotin affinity co-elution
For affinity co-elution assay, a 50-bp, 5’-biotin-tagged oligo and its complementary oligo 
were purchased from Sigma. The oligos were annealed by gradual cooling in a boiling water 
bath to generate a duplex oligo. Biotinylated dsOligo at a final concentration of 10 μM was 
mixed with 1 μg recombinant α-Syn (rPeptide) or 1 μg whole cell extract from SHSY-5Y 
cells ectopically expressing α-Syn or 1 μg purified BSA as a negative control in PBS and 
incubated at 30°C for 15 min with gentle shaking. The affinity pull-down was performed 
with Streptavidin-coupled Dynabeads™ M-280 (Thermo Scientific) following the 
manufacturer’s protocol. The eluted protein product was tested by immunoblotting.
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Oxidation of α-Syn by singlet oxygen
Singlet oxygen (1O2) was generated by irradiating riboflavin (Sigma R9504) solution (1% 
PBS) with UVB (UVP UVLMS-38). Recombinant α-Syn (2 μg) was added to the irradiated 
solution and incubated for 1 h followed by addition of supercoiled (sc) plasmid DNA for 4 h. 
To test oxidized α-Syn-mediated DNA strand breaks in cell, UVB-irradiated riboflavin 
solution containing recombinant α-Syn was added to the cell culture media for 4 h followed 
by DNA strand break analysis by Comet assay.
Comet assay
Alkaline Comet assay was performed using Trevigen’s Comet assay kit (#4250–050-K). 
Briefly, Dox-induced cells and empty vector cells treated with and without metals were 
lysed, resuspended in low melting agarose, and spread evenly onto Comet slides. The slides 
were immersed in freshly prepared alkaline unwinding solution prior to alkaline 
electrophoresis. DNA in the nucleoid was visualized with SYBR Gold staining using an 
EVOS FL auto-fluorescence microscope (Life Technologies). Comet tail moment was 
scored using the Open Comet plugin for ImageJ software with 50 randomly selected cells.
Long amplicon (LA)-polymerase chain reaction (PCR)
After exposure to redox metals for 24 h, iFLAG-α-Syn SHSY5Y cells, SNCA-tri iPSCs, and 
respective controls were harvested for genomic DNA isolation using DNeasy blood and 
tissue kit (Qiagen #69504) as per the manufacturer’s instructions. Genome integrity was 
assessed using LongAmp Taq DNA polymerase (NEB) to amplify a 10.4 kB region of the 
HPTR gene with the following primers: 5’-TGG GAT TAC ACG TGT GAA CCA ACC-3’ 
and 5’-GCT CTA CCC TCT CCT CTA CCG TCC-3’ [39]. PCR was performed at 94°C for 
3 min followed by 25cycles at 94°C for 30 s, 58°C for 40 s, and 65°C for 10 min, and a final 
elongation step for 15 min. A small region (250 bp) of the HPRT gene was amplified using 
Jump-Start RedTaq DNA polymerase (Sigma) to normalize amplification obtained from the 
large fragment using the following primers: 5’-TGC TCG AGATGT GAT GAA GG-3’ and 
5’-CTG CAT TGT TTT GCC AGT GT-3’ [40]. All amplified products were separated by 
electrophoresis in 0.8% agarose gel and stained with ethidium bromide. Relative DNA 
amplification percentage was calculated by gel band density analysis using ImageJ software 
or Pico Green dsDNA assay (Invitrogen, p7589).
Immunofluorescence
pCW-iFLAG-α-Syn SHSY-5Y cells were grown on 8-well chamber slides. Slides for iPSCs 
and NPCs were coated with Matrigel and Geltrex, respectively. Cells were fixed by replacing 
the media with fresh media and adding 8% PFA in PBS, obtaining a 4% PFA solution. Slides 
were then permeabilized with 0.2% Triton 100X in 1X PBS and blocked with 3% BSA-
PBS-T (1 × PBS with 0.1% Tween-20) and incubated with primary antibody for α-Syn 
EP1646Y (Novus Biologicals) and anti-DDK (Origene Clone 4CS TA50011). After 
incubation with Alexa Fluor 488 (green)- and 558 (red)-conjugated secondary antibodies, 
coverslips were mounted in DAPI (Sigma). Images were taken using an Olympus BX61-
Regular Upright BF & Fluorescent/Reflect Microscope using a 60 × objective.
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Thioflavin T (Thio T) fluorescence
Recombinant α-Syn was incubated in 0.01 M Tris-HCl (pH 7.4) at 37°C with vigorous 
stirring with a magnetic bar in glass vials. Aliquots were removed from the incubation mix 
at the indicated time intervals and diluted to appropriate concentrations for Thio T 
fluorescence measurements to assess the formation of protein aggregates. Fluorescence was 
measured using a HITACHI 2000 spectrofluorimeter from the emission spectra (470–650 
nm) with excitation at 450 nm using a 5-nm band pass for both excitation and emission.
For DNA cleavage analysis in vitro, aliquots of α-Syn (1 μM) from the aggregation reaction 
were mixed with 0.1 μg plasmid scDNA (pUC19) and incubated at 37°C for 4 h before 
being separated by 1% agarose gel electrophoresis.
Quantification of DNA strand breaks
Single-strand breaks (SSBs) were quantified using a nick translation reaction with E. coli 
DNA polymerase I (Klenow Fragment), which adds nucleotides at the 3’-OH end of an SSB 
[41]. When one of the dNTPs is P–32-labeled, the incorporation of radioactivity is 
proportional to the number of SSBs present in the DNA. The 50 μL reaction mixture 
consisted of 40 mM Tris-HCl (pH 8.0), 1 mM β-mercaptoethanol, 7.5 mM MgCl2, 4 mM 
ATP, 100 μM each of dATP, dCTP, and dGTP, 25 μM dTTP, 1 μCi3[H]TTP, 1 μg plasmid 
scDNA, and 1 unit of E. coli DNA polymerase I together with the indicated amounts of α-
Syn.
Double-strand breaks (DSBs) were quantified by a terminal transferase based assay [42]. 
Terminal deoxynucleotidyl transferase catalyzes the addition of deoxynucleotides to the 3’ 
termini of DNA at the blunt end. Similar conditions were used to incubate DNA with 
terminal transferase, as in the case of E. coli polymerase I assay. The incorporation of3[H]-
dTTP into DNA is proportional to the number of DSBs in the DNA. DNA breaks were 
quantified with reference to a control DNA with a known number of breaks as described 
previously [43].
Circular dichroism (CD) studies
CD spectra (190–300 nm) were recorded on a JASCO J-700 spectropolarimeter for aliquots 
of α-Syn withdrawn from aggregation reactions at various time intervals. The protein was 
diluted to a final concentration of 5 μM in 0.01 M Hepes buffer (pH 7.0). Each spectrum was 
the average of four repetitions. All spectra were corrected by subtraction from buffer spectra.
Flow-cytometric analysis of cell death
The levels of apoptosis in iFLAG-α-Syn cells ± Dox treatment after exposure to metal salts 
for 24 h was measured using the FITC Annexin V apoptosis detection kit I (BD Biosciences 
556547). Flow-cytometric analysis of apoptotic cell death was performed as indicated earlier 
[44]. Briefly, cells were harvested, washed with PBS, and incubated with fluorescein 
isothiocynate (FITC) conjugated Annexin V and propidium iodide (PI) according to the 
instruction of Annexin V apoptosis detection kit. A total of 10,000 events were acquired per 
sample by fluorescence activated cell sorting (FACS) and analyzed using Flowjo software 
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(Becton-Dickinson Biosciences, San Jose, CA). Unstained and single fluorochrome controls 
were used for background subtraction (data not shown).
Reactive oxygen species (ROS) measurement in live cells
CellROX green reagent (Life Technologies C10492), a dye that binds to DNA upon 
oxidation, was used to assess ROS accumulation in iFLAG-α-Syn SHSY-5Y cells ± Dox 
exposed for 24 h to Fe/Cu salts. After treatment, cells were stained with Cell-ROX green 
following the manufacturer’s protocol. The data from FACS acquisition was analyzed using 
Flowjo software.
Statistical analysis
Graphpad prism 6 software was used for data analysis. Comparisons of groups were 
generated with two-way Anova followed by Sidak’s or Tukey’s multiple comparison test to 
compare selected pair of means. p-values are indicated in the associated figure legends.
RESULTS
Chromatin association of nuclear α-Syn and its physical binding to naked DNA in vitro
Despite compelling evidence for the binding of α-Syn to DNA oligos in vitro, there are 
conflicting reports in the literature concerning the presence and role of α-Syn in neuronal 
nuclei, particularly in PD condition. The difficulty in establishing the presence of nuclear α-
Syn appears primarily due to its predominantly cytosolic localization in presynaptic nerve 
terminals and the presence of a relatively low fraction (<5%) of the protein in the nuclear 
compartment under normal conditions. To conclusively test α-Syn localization and its 
interaction with chromatin, we generated a Dox-inducible FLAG-α-Syn-expressing 
SHSY-5Y cell line (pCW-iFLAG-α-Syn SHSY-5Y line) allowing ectopic expression of α-
Syn in a controlled and reproducible fashion. Dox treatment (5 μg/mL) for 72 h gradually 
increased both ectopic FLAG-α-Syn and total α-Syn levels in the pCW-iFLAG-α-Syn 
SHSY-5Y line (Fig. 1A). A ~ 2- to 3-fold increase in total α-Syn level was consistently 
observed at 72 h after Dox induction. Immunofluorescence using FLAG or α-Syn antibody 
showed significant nuclear localization of α-Syn with an increase in its expression, as 
indicated in the enlarged image acquired at 72 h of Dox induction (Fig. 1B). We then 
utilized modified PLA, which is a highly sensitive for in situ detection of protein-protein 
interaction in cells [45]. Here, instead of two antibodies for different proteins used in typical 
PLA, we used FLAG versus α-Syn antibodies in the pCW-iFLAG-α-Syn SHSY-5Y line to 
detect ectopic α-Syn. A number of nuclear PLA foci within DAPI-stained regions confirmed 
the presence of FLAG-α-Syn in the nuclei (Fig. 1C, top). We then examined the association 
of α-Syn with chromatin. Strong PLA signals for FLAG versus histone H3 antibodies 
showed α-Syn binding to H3 in the chromatin (Fig. 1C, bottom).
To further confirm the chromatin association of α-Syn, we performed chromatin 
immunoprecipitation (ChIP) using FLAG antibody in pCW-iFLAG-α-Syn SHSY-5Y cells 
and then PCR-amplified the purified ChIP DNA with a set of four randomly selected primer 
pairs. These primers targeted proximal (–165/+82; promoter region) and distal (–72987/–
72800) regions of the RARβ2 gene and a randomly selected segment within chromosome 17 
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that does not harbor any gene signature, and the HPRT gene. Relatively high amplification 
of proximal RARβ2 promoter region was observed compared to its distal region, or the non-
gene region in chromosome 17 (Fig. 1D, Supplemental Figure 1A). Moderately high binding 
was also observed for HPRT gene (Supplementary Figure 1B). These data not only 
suggested an association between α-Syn and chromatin but also indicated the possible 
functional binding of α-Syn to distinct chromosomal regions containing specific genes. 
However, we decided to pursue the functional implications of distinct and specific chromatin 
binding of α-Syn in a separate study and focus on the general pathological impact of α-Syn 
toxicity on neuronal genomes in the present study. Furthermore, we tested whether α-Syn 
binds to naked DNA in vitro using a biotin affinity co-elution analysis. Immunoblotting 
revealed that both recombinant α-Syn (Rec.α-Syn) and α-Syn in the SHSY-5Y nuclear 
extract co-eluted with a biotin-tagged duplex oligonucleotide (Fig. 1E). Together, these data 
demonstrate that α-Syn binds to DNA and chromatin both in cells and in vitro.
α-Syn expression induces strand breaks in the neuronal genome synergistically with Fe
The evidence for the presence of extensive genome damage in PD-affected human brains 
and various PD model systems [29–31] led us to examine DNA breaks in α-Syn-
overexpressing cells in presence of pro-oxidant Fe or Cu salts. Fe has been shown to 
accumulate in α-Syn-rich Lewy bodies in the PD brain and within α-Syn-rich inclusions in 
PD neuronal cells [6, 46]. Alkaline Comet assay of the pCW-iFLAG-α-Syn SHSY-5Y line 
showed a pronounced increase in mean comet tail moment 48 h after Dox induction, which 
was further enhanced in FeSO4-treated cells (Fig. 2A, B). Five-fold increase in genome 
damage was caused by ~2-fold induction of α-Syn. The presence of FeSO4 resulted in about 
an 8-fold increase in strand breaks in α-Syn-overexpressing cells. Unlike FeSO4, which 
showed synergistic toxicity when combined with α-Syn, CuSO4 showed only an additive 
effect. A similar dose of FeSO4 and CuSO4 exposure in uninduced pCW-iFLAG-α-Syn 
SHSY-5Y cells caused only moderate (<2-fold) increase in the mean comet tail moment. 
LA-PCR analysis of the genomic DNA isolated from the above cells confirmed marked 
reduction in genomic integrity in Fe-treated, α-Syn-overexpressing cells (Fig. 2C, D). 
Amplification of a 10.4 kb and a shorter 250 bp region within the HPRT gene followed by 
agarose gel electrophoresis (Fig. 2C) and gel band density-based quantification (Fig. 1D) 
showed 30% decrease in amplified product in α-Syn-overexpressing cells. A reduction in 
amplified product in LA-PCR indicates the presence of strand breaks within the amplified 
region [39]. Consistent with Comet analysis, a further 45% and 70% decrease was observed 
in CuSO4-and FeSO4-treated cells, respectively (Fig. 2C, D). Similarly, addition of 
recombinant α-Syn to cultured SHSY-5Y cells combined with Fe cooperatively induced 
extensive DNA damage (Supplementary Figure 2).
Nuclear but not cytosolic α-Syn induces neuronal genome damage
To test the direct role of nuclear α-Syn in causing genome damage, we transiently 
transfected SHSY-5Y cells with mutant α-Syn expression vectors containing additional NLS 
or NES sequences. Immunofluorescence (Fig. 3A) and immunoblotting (Fig. 3B) confirmed 
the nuclear- and cytosolic expression of NLS-α-Syn and NES-α-Syn, respectively. Comet 
analysis showed about 2-fold higher mean tail moment for NLS-α-Syn-expressing cells 
compared with WT-α-Syn or NES-α-Syn cells (Fig. 3C, D). The damage was further 
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enhanced after Fe or Cu treatment in NLS-α-Syn and WT-α-Syn cells but not in NES-α-Syn 
cells. These data thus demonstrate that the nuclear localization of α-Syn is required for 
inducing genome damage in neurons.
DNA nicking activity of α-Syn is enhanced by misfolding/oligomerization.
We next examined the effect of α-Syn binding on plasmid scDNA using recombinant protein 
in vitro. Separation of plasmid DNA by agarose gel electrophoresis after incubation with α-
Syn for 12 h showed conversion of the scDNA form into a mixture of open circular and 
linear forms together with shorter sheared fragments (Fig. 4A). Quantification of breaks in 
plasmid DNA using a nick translation method [29, 43] showed 6-fold increase in SSBs but 
only a moderate increase in DSBs (Fig. 4B).
We then correlated the misfolding/aggregation of α-Syn with its DNA nicking activity. 
Aliquots of α-Syn incubated with constant stirring for promoting aggregation, as monitored 
by Thio T fluorescence (Fig. 4C), were mixed with scDNA, and strand breaks were 
quantified by agarose gel (Fig. 4D) and nick translation (Fig. 4E). Interestingly, the 
misfolded or early oligomeric α-Syn indicated by CD spectroscopy (Fig. 4F) caused higher 
DNA damage compared with monomeric or aggregated forms. This is again consistent with 
the model of higher toxicity of α-Syn oligomers [47].
Oxidation of α-Syn may promote its DNA nicking activity
α-Syn has been shown to oxidize in PD conditions [13]. Based on this previous observation 
and the enhancement of DNA nicking activity by α-Syn-pro-oxidant metal complex in our 
study, we suspected that the oxidized form of α-Syn might mediate DNA cleavage. To test 
this possibility, we exposed riboflavin with UVB to generate1O2 before incubation with α-
Syn for 1 h followed by mixing with scDNA. Agarose gel electrophoresis showed significant 
shearing of DNA by oxidized α-Syn compared with WT-α-Syn or1O2-treated DNA (Fig. 
5A). We then treated SHSY-5Y cells with WT- or oxidized α-Syn and quantified genome 
damage by Comet analysis (Fig. 5B). Consistent with the in vitro data, an ~5-fold higher 
mean tail moment was observed with oxidized α-Syn versus a 2-fold increase with WT-α-
Syn. These data suggest that oxidized α-Syn is critical for inducing genome damage. Similar 
chemical nuclease activity of short oxidized peptides containing oxidizable Tyr or Thr 
residues together with basic residues has been previously characterized [48]. These peptides 
extract protons from phosphodiester bonds in the DNA backbone to nick DNA. It is likely 
that α-Syn-mediated genome damage involves a similar chemical nicking mechanism.
Fe-dependent ROS generation after α-Syn induction in neurons
We observed a significant increase in ROS-positive cells after α-Syn in the presence of 
FeSO4 but not in the presence of CuSO4 (Fig. 6A, B). Fluorescence microscopy revealed 
increased α-Syn aggregate formation in the perinuclear region of FLAG-α-Syn-
overexpressing cells exposed to FeSO4 (Fig. 6C). However, the negligible increase in ROS 
with CuSO4 was surprising but is likely due to activation of Cu/Zn superoxide dismutase by 
Cu to quench ROS [49].
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α-Syn-induced genome damage in NPC lines derived from PD patient iPSC cells
Given that a small pool of neural stem cells are a potential source for replacing degenerated 
neurons in PD patients [50], we generated NPC lines from a normal or PD patient–derived 
SNCA-tri iPSC cells and characterized the NPCs with appropriate markers (Fig. 7A–C). The 
SNCA-tri iPSC line possesses SNCA gene triplication and thus shows ~3-fold 
overexpression in α-Syn levels and up to ~5-fold overexpression upon conversion to NPC, 
as confirmed by immunofluorescence (Fig. 7C) and mRNA quantitation by RT-PCR (Fig. 
7D), consistent with previous studies [51]. DNA damage analysis by LAPCR showed 
presence of significantly higher number of DNA strand breaks in SNCA-tri NPC cells 
compared to control NPC cells (Fig. 7E), as indicated by ~30% reduced amplification of 
HPRT gene long amplicon quantified using Pico Green dsDNA assay (Fig. 7F). Exposure to 
200 μM FeSO4 synergistically increased DNA damage in SNCA-tri NPC cells over the 
control. The moderate synergy of Fe in SNCA-tri NPC cells (Fig. 7 E, F) over transiently 
induced α-Syn in pCW-iFLAG-α-Syn SHSY-5Y line (Fig. 2) may be attributed to the 
constitutive overexpression of α-Syn in SNCA-tri NPC line, which may sequester cellular 
Fe. On the other hand, CuSO4 induced DNA damage is comparable to that in Fe-treated 
NPC cells, unlike in SHSY-5Y cells, presumably due to their differential antioxidant 
capacity. Furthermore, treatment of control NPC cells with 300 nM recombinant α-Syn 
together with 200 μM FeSO4 resulted in a ~ 22% reduction in HPRT gene amplification 
product (Supplementary Figure 2B).
α-Syn and Fe cooperatively induce neuronal apoptosis
To further address the Fe-dependent neurotoxicity of α-Syn, we performed Annexin V-
FITC/PI dual staining pCW-iFLAG-α-Syn SHSY-5Y cells with or without Fe/Cu. The cells 
were induced for 48 h with Dox, which resulted in ~12% increase in early (Q3) and late 
(Q2) apoptotic cell population. Both un-induced and induced cells were then exposed to 
FeSO4 or CuSO4. A 4–8% cell population migrated directly from Q1 to Q4 in un-induced 
cells after Fe/Cu treatment, which presumably represents a combination of necrosis and 
ferroptosis [52, 53] (Fig. 8A). However, Fe caused a significant increase (~ 16%) in early 
and late apoptotic cells (quantitated from Q2 and Q3, respectively) in Dox-induced cells 
(Fig. 8A, B). CuSO4 did not affect α-Syn-mediated neuronal apoptosis in Dox-induced 
cells. Interestingly, Fe- or Cu- induced necrosis or possible ferroptosis (Q4) observed in un-
induced cells was prevented after α-Syn induction. This is likely due to sequestration of free 
metal ions by overexpressed α-Syn, preventing metal mediated necrosis/ferroptosis.
DISCUSSION
Our results demonstrate novel DNA cleavage activity of α-Syn both in vitro and in genomes 
of cultured neurons. This activity was upregulated in the presence of pro-oxidant Fe as well 
as1O2. We first established that nuclear-localized α-Syn binds to distinct DNA sequences in 
the chromatin and physically binds naked DNA in vitro. To gain further molecular insights 
into α-Syn’s DNA binding and nicking activity, we used MD simulation with nucleic acid-
protein docking method (NPDock) [54] to predict the three-dimensional structure of the α-
Syn-DNA complex (Fig. 9 and Supplementary Figure 3). The DNA was predicted to interact 
with the positively charged lysine-rich repeat motifs (KTKEGV) located predominantly in 
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the N-terminus and partly in the central domains of the α-Syn sequence. The DNA is highly 
unlikely to bind to the C-terminal end of α-Syn, which is rich in negatively charged 
residues. Consistently, previous studies show that α-Syn has a propensity to form broken 
helices in the N-terminal region owing to the presence of several 11 amino acid repeats that 
may form a helix-turn-helix type of motif that is commonly present in many classical DNA-
binding proteins [55, 56]. After α-Syn’s initial electrostatic interaction with the DNA 
backbone, subtle conformational change in α-Syn, induced by its oxidation or by Fe, could 
stabilize the interaction facilitating DNA nicking activity. In cells, however, α-Syn 
interaction with histone proteins (Fig. 1C) may contribute to the initial chromatin binding.
Although α-Syn is primarily a presynaptic nerve terminal protein that is predominantly 
enriched in the membrane, several studies show the presence of α-Syn in neuronal nuclei 
[18, 21, 23, 24]. However, the functional or pathological implications of nuclear α-Syn are 
unclear. Ma et al. suggest that residues (103–140) located at the C-terminus of α-Syn are 
critical for its nuclear localization [22]. They have also proposed involvement of importin α, 
a nuclear-transport receptor protein, in the translocation of α-Syn into the nucleus. Although 
no direct interaction between α-Syn and importin α was observed, the authors suggest the 
involvement of other proteins mediating complex formation. Another recent study reported 
the role of a tripartite motif-containing protein 28 (TRIM28) in stabilizing α-Syn in the 
neuronal nucleus [25]. TRIM28 contains an NLS sequence that interacts with various 
importin α subtypes, facilitating its nuclear import where it binds to chromatin [57, 58]. 
TRIM28, along with importin α, may thus play a role in α-Syn’s nuclear import, which 
should be further investigated. Moreover, under PD condi tions, α-Syn nuclear localization 
is likely enhanced due to non-specific transportation through the oxidatively damaged 
nuclear membrane [11]. Recent studies showed that overexpressed α-Syn accumulates in the 
perinuclear region, which is consistent with our findings. Cells exposed to Fe have been 
found to present Fe-rich α-Syn inclusions within the perinuclear regions [46]. Interestingly, 
Fe has also been found to disrupt the nuclear membrane, allowing perinuclear α-Syn to 
translocate into disrupted nuclei [59]. Thus, both physiological and pathological conditions 
could favor α-Syn’s nuclear localization in PD-affected neurons.
The fact that increased oxidative stress and Fe accumulation are hallmarks of the PD brain, 
led us to investigate the impact of these conditions on α-Syn-DNA interaction. We observed 
that α-Syn overexpression combined with Fe exposure or oxidative stress significantly 
enhanced DNA damage in the neuronal genome. Furthermore, genome damage was 
dependent on nuclear α-Syn as determined by the expression of NLS or NES mutants. On 
the other hand, cytosol-specific α-Syn expression inhibited DNA breaks formation even in 
the presence of metal salts, likely due to their sequestration by oligomeric α-Syn. 
Furthermore, the enhanced DNA nicking activity of α-Syn after its exposure to1O2 or Fe, 
suggests that oxidized α-Syn is involved in causing DNA strand-breaks, likely by acting as a 
chemical nuclease. It was previously shown that when surrounded by basic residues, 
peroxides of Trp, Tyr, Met, Asp, Pro, and Cys in proteins formed by ROS and/or transition 
metals, acquire DNA strand cleavage activity, by abstracting a proton from the 
phosphodiester linkage, causing its cleavage [48]. It is likely that a similar mechanism is 
involved in α-Syn induced DNA damage. Fe ions could contribute to α-Syn oxidation via 
their binding to oxidation prone residues such as Met, Cys, Thr, Tyr, and Trp in α-Syn. 
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Interestingly, we found that the DNA cleavage level was the highest with misfolded/
oligomeric α-Syn, suggesting that exposure of oxidation-prone regions may be critical. We 
propose that blocking oxidation prone peptide sequence in combination with metal chelators 
could be an effective therapeutic strategy, which we are currently investigating. In cells, α-
Syn folding could be promoted by accumulated redox active metal ions, as was reported by 
our lab [60, 61] and others [9, 10]. In addition to α-Syn, Aβ, tau and prion proteins 
implicated in AD and prion diseases, also have DNA binding activity, suggesting that DNA 
binding is a common property of many amyloidogenic proteins associated with various 
neurodegenerative disorders [28, 62–64]. However, the role of their DNA binding in disease 
pathology has not been well studied.
In addition to Fe, previous studies have showed that α-Syn binds Cu in vitro. Cu was shown 
to bind the1MVDFM5 motif in the α-Syn N-terminus and promote its oligomerization [14]. 
However, our in cell data show no synergistic neurotoxicity or genome damage by α-Syn 
and Cu. This raises the question about the in vivo relevance of toxicity of Cu-α-Syn 
complex for PD. Unlike the available compelling evidence for Fe accumulation, Cu has not 
been consistently shown to accumulate in the PD brain, nor in Lewy body inclusions. 
Furthermore, Cu at low concentrations could activate superoxide dismutase, and thus may 
protect cells from ROS toxicity [49]. Although both Fe and Cu are redox-active, they have 
the distinct ability to affect α-Syn-mediated neurotoxicity. Furthermore, Fe and Cu caused a 
small but subtle increase in non-apoptotic cell death (Q1 to Q4 migration in Fig. 8) in 
cultured neurons in the absence of α-Syn, which was prevented by α-Syn overexpression, 
although apoptotic cell population increased. While the nature of this direct metal induced 
cell death is not clear, it is possible that both necrosis and recently discovered ferroptosis 
[52] contributes to the pathway triggered by direct exposure to free metals in cultured cells 
that lack robust metal storage/sequestration machinery. Recent studies show that activation 
of ferroptosis plays a role in the nonapoptotic destruction of cancer cells, but its inhibition 
may protect from neurodegeneration. The prevention of such non-apoptotic cell death after 
α-Syn induction suggests that moderate increase in α-Syn may be protective against Fe-
induced ferroptosis, which should be the subject of future investigation.
It is important to note that α-Syn primarily forms SSBs in DNA. However, with prolonged 
incubation with α-Syn in vitro, DSBs were formed in plasmid DNA, presumably due to the 
accumulation of several SSBs in close proximity. A schematic representation of the DNA 
cleavage mechanism of α-Syn is shown in Fig. 10. Our studies thus highlight the role of α-
Syn in inducing DNA cleavage and the contribution of ROS or pro-oxidant Fe/Cu to this 
process, which may have a profound impact on our approach to PD prevention and therapy.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Nuclear localization and chromatin/DNA binding of α-Syn. A, B) Characterization of time-
dependent induction of FLAG-α-Syn in a SHSY-5Y cell line stably harboring tet-on (Dox-
inducible) pCW-iFLAG-α-Syn vector. Immunoblotting (A) and immunofluorescence (B) 
revealed a time-dependent increase (2–4-fold) in both FLAG and total α-Syn levels after 
induction with Dox for 24–72 h in differentiated cells. The presence of nuclear α-Syn after 
72 h of Dox induction is indicated in the enlarged image. C) PLA of FLAG versus α-Syn 
antibody in pCW-iFLAG-α-Syn SHSY-5Y cells. A PLA focus in the nucleus (DAPI) 
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detected the same molecule of ectopic α-Syn. PLA of FLAG versus histone H3 antibody 
confirmed interaction with H3 in the nucleus. D) ChIP assay using FLAG antibody from 
pCW-iFLAG-α-Syn SHSY-5Y cells after Dox induction (72 h) and real-time PCR 
amplification using three randomly selected primer pairs. E) In vitro biotin affinity co-
elution analysis. Immunoblotting of SHSY-5Y cell nuclear extract or recombinant α-Syn co-
eluted with biotin-labeled duplex DNA oligo.
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Fig. 2. 
Increased α-Syn expression causes DNA breaks in neurons synergistically with pro-oxidant 
metals. A, B) Alkaline Comet assay in iFLAG-α-Syn SHSY-5Y cells exposed to 200 μM 
FeSO4 or CuSO4. α-Syn was induced with Dox for 48 h. Metal salts alone at the same 
concentration caused only moderate increases in strand breaks. C, D) Semi-quantitative LA-
PCR assay for genomic DNA isolated from pCW-iFLAG-α-Syn SHSY-5Y cells in the 
presence of FeSO4 or CuSO4. ***p ≤ 0.001; ****p ≤ 0.0001.
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Fig. 3. 
Nuclear α-Syn is required for inducing genome damage in neurons. A) Immunofluorescence 
images demonstrating nucleus- or cytoplasm-specific expression of mutant α-Syn vectors 
containing additional NES or NLS after their transient transfection in SHSY-5Y cells. B) 
Immunoblotting of cytosolic and nuclear fractions from WT-, NES-, and NLS-α-Syn-
expressing SHSY-5Y cells. C, D) Alkaline Comet assay in NLS-, NES-, or WT-α-Syn-
expressing cells with or without FeSO4 or CuSO4.
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Fig. 4. 
Recombinant α-Syn nicks naked DNA in vitro, which is enhanced by its misfolding/
oligomerization. A) Agarose gel electrophoresis showing plasmid scDNA cleavage by 
recombinant α-Syn. B) Assessment of SSBs and DSBs in scDNA induced by α-Syn. Values 
are expressed as SSBs and DSBs induced per μg of scDNA. C) Recombinant α-Syn was 
incubated with constant stirring to cause its aggregation, which was monitored by Thio T 
fluorescence analysis with an aliquot of α-Syn taken at various time intervals. D) The α-Syn 
aliquots were also analyzed for their DNA nicking activity with plasmid DNA by agarose 
gel electrophoresis. E) DNA breaks were quantified. F) Misfolding/β-sheet formation in α-
Syn upon stirring as confirmed by CD spectroscopy.
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Fig. 5. 
α-Syn DNA nicking activity may be mediated by its oxidation. A) Exposure of recombinant 
α-Syn to1O2, generated by exposing flavonoid Bengal red to UVB radiation, enhanced its 
DNA nicking activity with plasmid scDNA in vitro. The products were analyzed by agarose 
gel electrophoresis. The histogram represents quantification of DNA fragmentation. B) 
SHSY-5Y cells were exposed to similarly oxidized α-Syn, and DNA damage was quantified 
by alkaline Comet assay.
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Fig. 6. 
Fe-dependent ROS generation and α-Syn aggregation in pCW-iFLAG-α-Syn SHSY-5Y 
cells. A, B) Cells treated with FeSO4 but not CuSO4 showed a significant increase in nuclear 
and mitochondrial ROS load. Results are presented as percentage of ROS-positive cells; 
error bars in the histogram represent the standard error of the mean (SEM) from three 
independent experiments. C) Immunofluorescence indicates α-Syn aggregate formation in 
FeSO4-treated cells. **p ≤ 0.01.
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Fig. 7. 
DNA damage in neurons generated from normal and PD patient-derived SNCA-tri iPSC 
cells. A) Phase contrast image demonstrating generation of NPCs from iPSCs: (a) SNCA-tri 
iPSCs cultured in MEF feeder layer, (b) SNCA-tri iPSCs cultured in feeder free layer, (c) 
day 2, (d) day 4, (e) day 6 of neural induction for NPC derivation, (f) NPC at passage 3. The 
iPSC specific marker Oct4 and neural precursor markers nestin analyzed by immunoblotting 
(B). C) Immunofluorescence characterization with nestin and α-Syn protein expression. D) 
α-SYN mRNA quantitation in control versus SNCA-tri iPSC and NPC cells. E, F) LA-PCR 
analysis of genomic DNA isolated from control or SNCA-tri NPC cells exposed to 200 μM 
FeSO4 or CuSO4. ***p ≤ 0.001.
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Fig. 8. 
α-Syn and Fe synergistically induce neuronal apoptosis. A) pCW-iFLAG-α-Syn SHSY-5Y 
cells were induced with Dox for 48 h and then treated with 200 μM FeSO4 or CuSO4 for 24 
h before being double-stained with Annexin V/PI and analyzed by flow cytometry. 
B)Results are presented as percentage of total apoptotic cells (early apoptotic (Q3)+ late 
apoptotic (Q2)). Error bars represent the SEM from three independent experiments. Fe or Cu 
alone caused a 4–8% necrosis (Q4) in uninduced cells, which was prevented by α-Syn 
induced cells. *p ≤ 0.05; **p ≤ 0.01.
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Fig. 9. 
MD simulation: α-Syn N-terminal residues may be involved in DNA binding. Protein-DNA 
docking Model 1 demonstrating binding of α-Syn (PDB: 1XQ8) N-terminal amino acid 
residues Glu-35, Ser-42, Thr-54 to the crystal structure of d(CCGGTACCGG) as a B-DNA 
duplex (PDB: 3IXN). This structure model represents the best structure from the biggest 
cluster after the refinement process. Structures were analyzed using PyMOL Molecular 
Graphics System, Version 1.7.4.5 Schrödinger, LLC.
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Fig. 10. 
Model illustrating how α-Syn-induced DNA breaks contributes to neuronal apoptosis in PD. 
The role of pro-oxidant Fe or ROS in promoting α-Syn misfolding and oxidation, which 
could exacerbate its DNA nicking activity.
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